NCT03066219View on ClinicalTrials.gov

Safety and Efficacy of BRM421 for Dry Eye Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

February 7, 2017

Primary Completion Date

May 20, 2017

Study Completion Date

June 28, 2017

Conditions
Dry Eye Syndrome
Interventions
DRUG

BRM421

A topical solution of BRIM421 ophthalmic drops

DRUG

Placebo

vehicle ophthalmic drops

Trial Locations (2)

04240

Central Maine Eye Care, Lewiston

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

BRIM Biotechnology Inc.

INDUSTRY